Cargando…

Epidemiology of psoriasis in hard-to-treat body locations: data from the Danish skin cohort

BACKGROUND: Having psoriasis in hard-to-treat areas, i.e. the scalp, face, palms, soles, nails, and genitals, respectively, can impair patients’ quality of life. We investigated the prevalence of hard-to-treat body locations of psoriasis, and described patients’ clinical and demographic characterist...

Descripción completa

Detalles Bibliográficos
Autores principales:	Egeberg, Alexander, See, Kyoungah, Garrelts, Alyssa, Burge, Russel
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2020
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7238562/ https://www.ncbi.nlm.nih.gov/pubmed/32434510 http://dx.doi.org/10.1186/s12895-020-00099-7

Ejemplares similares

Rapid Response of Biologic Treatments of Moderate-to-Severe Plaque Psoriasis: A Comprehensive Investigation Using Bayesian and Frequentist Network Meta-analyses
por: Warren, Richard B., et al.
Publicado: (2019)

Number Needed to Treat Network Meta-Analysis to Compare Biologic Drugs for Moderate-to-Severe Psoriasis
por: Leonardi, Craig L., et al.
Publicado: (2022)

Patient characteristics and disease burden of alopecia areata in the Danish Skin Cohort
por: Andersen, Yuki M F, et al.
Publicado: (2022)

Prevalence and characteristics of psoriasis in Denmark: findings from the Danish skin cohort
por: Egeberg, Alexander, et al.
Publicado: (2019)

Psoriasis Severity Assessment Combining Physician and Patient Reported Outcomes: The Optimal Psoriasis Assessment Tool
por: Leonardi, Craig, et al.
Publicado: (2021)

Dynamic Visual Representation of Clinical Efficacy of Ixekizumab in Psoriasis
por: Hawkes, Jason E., et al.
Publicado: (2021)

Cumulative Clinical Benefits of Biologics in the Treatment of Patients with Moderate-to-Severe Psoriasis over 1 Year: a Network Meta-Analysis
por: Blauvelt, Andrew, et al.
Publicado: (2022)

Predictors of Response to Biologics in Patients with Moderate-to-severe Psoriasis: A Danish Nationwide Cohort Study
por: SCHWARZ, Christopher Willy, et al.
Publicado: (2021)

A Retrospective Cohort Analysis of Treatment Patterns Over 1 Year in Patients with Psoriasis Treated with Ixekizumab or Guselkumab
por: Blauvelt, Andrew, et al.
Publicado: (2022)

Relationship Between Rapid Skin Clearance and Quality of Life Benefit: Post Hoc Analysis of Japanese Patients with Moderate-to-Severe Psoriasis Treated with Ixekizumab (UNCOVER-J)
por: Honma, Masaru, et al.
Publicado: (2020)

Letter to the Editor: Response to Fitzgerald T et al. Long-Term Psoriasis Control with Guselkumab, Adalimumab, Secukinumab, or Ixekizumab in the USA
por: Blauvelt, Andrew, et al.
Publicado: (2023)

Injection Site Reactions in the Federal Adverse Event Reporting System (FAERS) Post-Marketing Database Vary Among Biologics Approved to Treat Moderate-To-Severe Psoriasis
por: Grace, Elsie, et al.
Publicado: (2019)

Comorbidities, socioeconomic status, drug use, and health care consumption in Danish women with psoriasis: A nationwide cross-sectional study
por: Johansen, Cæcilie Bachdal, et al.
Publicado: (2020)

Psoriasis and New-Onset Diabetes: A Danish nationwide cohort study
por: Khalid, Usman, et al.
Publicado: (2013)

Treatment Goals for Psoriasis as Measured by Patient Benefit Index: Results of a National Psoriasis Foundation Survey
por: Armstrong, April, et al.
Publicado: (2022)

Simultaneous Nail and Skin Clearance in Ixekizumab Head-to-Head Trials for Moderate-to-Severe Psoriasis and Psoriatic Arthritis
por: Elewski, Boni E., et al.
Publicado: (2022)

The risk of COVID-19 in patients with psoriasis: A retrospective cohort study
por: Wu, Jashin J., et al.
Publicado: (2022)

Comparison of Real-World Treatment Patterns Among Psoriasis Patients Treated with Ixekizumab or Adalimumab
por: Blauvelt, Andrew, et al.
Publicado: (2020)

Psoriasis Carries an Increased Risk of Venous Thromboembolism: A Danish Nationwide Cohort Study
por: Ahlehoff, Ole, et al.
Publicado: (2011)

Interaction between interleukin-10 (IL-10) polymorphisms and dietary fibre in relation to risk of colorectal cancer in a Danish case-cohort study
por: Andersen, Vibeke, et al.
Publicado: (2012)

Response to Biologics During the First Six Months of Therapy in Biologic-naïve Patients with Psoriasis Predicts Risk of Disease Flares: A Danish Nationwide Study
por: LOFT, Nikolai, et al.
Publicado: (2021)

The Development of the Genital Psoriasis Sexual Frequency Questionnaire (GenPs-SFQ) to Assess the Impact of Genital Psoriasis on Sexual Health
por: Gottlieb, Alice B., et al.
Publicado: (2017)

The Development of a Patient-Reported Outcome Measure for Assessment of Genital Psoriasis Symptoms: The Genital Psoriasis Symptoms Scale (GPSS)
por: Gottlieb, Alice B., et al.
Publicado: (2017)

Healthcare Costs Among Patients with Psoriasis Treated with Ixekizumab Versus Secukinumab in Real-World Settings Over 24 Months
por: Blauvelt, Andrew, et al.
Publicado: (2022)

Comparison of Real-World Treatment Patterns Among Biologic-Experienced Patients with Psoriasis Treated with Ixekizumab or Secukinumab Over 18 Months
por: Blauvelt, Andrew, et al.
Publicado: (2021)

Cost per cumulative clinical benefit of biologic therapies for patients with plaque psoriasis: a systematic review
por: Blauvelt, Andrew, et al.
Publicado: (2021)

Existing Data Sources in Clinical Epidemiology: The Danish COVID-19 Cohort
por: Pottegård, Anton, et al.
Publicado: (2020)

A nationwide population‐based cohort study of the incidence of severe and rare infections among adults with psoriasis in Denmark
por: Loft, Nikolai, et al.
Publicado: (2022)

The impact of comorbidities on interleukin-17 inhibitor therapy in psoriatic arthritis: a Danish population-based cohort study
por: Petersen, Magnus B, et al.
Publicado: (2023)

Outcomes of Biologic Use in Asian Compared with Non-Hispanic White Adult Psoriasis Patients from the CorEvitas Psoriasis Registry
por: Yu, Chen, et al.
Publicado: (2022)

Treatment Persistence of Ixekizumab in Adults with Moderate-to-Severe Plaque Psoriasis Participating in the Canadian Patient Support Program
por: Gulliver, Wayne, et al.
Publicado: (2022)

Hit hard and early: Can the march of psoriasis be halted?
por: Jandhyala, Sridhar
Publicado: (2013)

Effectiveness of Brodalumab in Patients with Moderate-to-Severe Plaque Psoriasis Located in Difficult-to-Treat Areas
por: Cacciapuoti, Sara, et al.
Publicado: (2023)

No associations between type 1 diabetes and atopic dermatitis, allergic rhinitis, or asthma in childhood: a nationwide Danish case-cohort study
por: Berg, Anna Korsgaard, et al.
Publicado: (2023)

Epidemiology of Hyperhidrosis in Danish Blood Donors
por: HENNING, Mattias A. S., et al.
Publicado: (2021)

Prognosis after percutaneous coronary intervention in patients with psoriasis: a cohort study using Danish nationwide registries
por: Ahlehoff, Ole, et al.
Publicado: (2012)

Existing data sources for clinical epidemiology: Danish Cancer in Primary Care cohort
por: Jensen, Henry, et al.
Publicado: (2014)

Residential Radon Exposure and Skin Cancer Incidence in a Prospective Danish Cohort
por: Bräuner, Elvira Vaclavik, et al.
Publicado: (2015)

Treatment Patterns in Danish Patients with Atopic Dermatitis Before and After Hospital Referral
por: Egeberg, Alexander, et al.
Publicado: (2021)

An evaluation of mechanical and biophysical skin parameters at different body locations
por: John, Anto J. U. K., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_990uel8gpud8ok79lnnt7tfa3q